scholarly journals Hospital patients mobility trends among the Italian regions: 1998-2008

2013 ◽  
Vol 23 (suppl_1) ◽  
Author(s):  
G Messina ◽  
G Prisco ◽  
L Gialluca ◽  
C Bedogni ◽  
F Moirano ◽  
...  
2021 ◽  
Vol 4 (6) ◽  
Author(s):  
Nante N

Background: The analysis of mobility flows (movement of patients to hospital away from the place of residence) involves aspects of services quality (real/perceived), equity of access to healthcare and considerable financial flows. This work has a methodological meaning and summarizes the author’s experience over the years in order to demonstrate the usefulness of Gandy’s Nomogram (Cartesian graphic tool) to evaluate hospital patients’ mobility at MACRO, MESO and MICRO level. Materials and Methods: We analysed data of Hospital Discharge Cards (HDCs) produced by Italian hospital and provided by the HDCs Database of General Directorate for Health Planning of Ministry of Health from 1998 to 2019. We used also data produced by Management Control of Polyclinic of Siena from 1988 to 2007. The subjects of the analysis (catchment areas) were hospital networks of single Italian regions and in particular the Province of Siena. The study of flows was developed through Gandy’s Nomogram. The trend analysis was carried out through STATA 14. Results: Gandy’s Nomogram of inter-regional mobility showed that there was a concentration of critical situations, especially in southern Italy, where only Basilicata seemed to have embarked on a clear path for enhancing hospital supply during the studied period. The regions of Centre-North, in particular Lombardy, Emilia Romagna and Friuli-Venezia Giulia appeared to be in virtuous conditions. Conclusion: Gandy’s Nomogram, used to represent health mobility flows, has proven to be a practical graphical tool that can provide a geographical interpretation of access to health services and it is useful for health policy evaluation and planning


2018 ◽  
Vol 6 (1) ◽  
pp. 41-45 ◽  
Author(s):  
Marina Falanga ◽  
Augusta Canzona ◽  
Davide Mazzoni

This article focuses on the patients’ acceptance of a subcutaneous injection device for patients with systemic lupus erythematosus, which in the upcoming years could be introduced beside the intravenous infusion of biological therapy. An online questionnaire was completed by 548 patients from different Italian regions. The preference for subcutaneous injection was 41.2%, for intravenous infusion was 36.9%, and 21.9% were uncertain. Patients with previous experience of biological therapies were less uncertain ( P = .001). The reported motivations for the preference were analyzed through a lexicometric approach with the software T-LAB. Results revealed that respondents who preferred subcutaneous injections reported motivations that were more related to convenience, avoiding the discomfort of reaching the hospital. Patients who preferred intravenous infusion emphasized the importance of safety feelings related to the presence of qualified assistance during the therapy administration. In conclusion, patients appreciated the convenience that characterizes subcutaneous injections but also emphasized the importance of feeling safe during the administration. The study suggests that the choice of prescribing subcutaneous injections or intravenous infusions should be shared with patients, discussing possible resistances and avoiding preconceptions about patients’ preferences.


2008 ◽  
Author(s):  
Jared A. DeFife ◽  
Rebecca L. Drill ◽  
Jack Beinashowitz ◽  
Ash Turnbull ◽  
Elizabeth B. Naughter

1983 ◽  
Vol 50 (02) ◽  
pp. 541-542 ◽  
Author(s):  
J T Douglas ◽  
G D O Lowe ◽  
C D Forbes ◽  
C R M Prentice

SummaryPlasma levels of β-thromboglobulin (BTG) and fibrinopeptide A (FPA), markers of platelet release and thrombin generation respectively, were measured in 48 patients within 3 days of admission to hospital for acute chest pain. Twenty-one patients had a confirmed myocardial infarction (MI); 15 had unstable angina without infarction; and 12 had chest pain due to noncardiac causes. FPA and BTG were also measured in 23 control hospital patients of similar age. Mean plasma BTG levels were not significantly different in the 4 groups. Mean plasma FPA levels were significantly higher in all 3 groups with acute chest pain when compared to the control subjects (p < 0.01), but there were no significant differences between the 3 groups. Increased FPA levels in patients with acute chest pain are not specific for myocardial infarction, nor for ischaemic chest pain.


2017 ◽  
pp. 27-43
Author(s):  
Elena Cappellini ◽  
Silvia Duranti ◽  
Valentina Patacchini ◽  
Carla Rampichini ◽  
Nicola Sciclone

Sign in / Sign up

Export Citation Format

Share Document